Phase I Randomized Placebo-controlled, Double-blind Study of the Safety and Tolerability of Bremelanotide Coadministered With Ethanol in Healthy Male and Female Participants.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Phase I Randomized Placebo-controlled, Double-blind Study of the Safety and Tolerability of Bremelanotide Coadministered With Ethanol in Healthy Male and Female Participants.
- Published In:
- Clinical therapeutics, 39(3), 514-526.e14 (2017)
- Authors:
- Clayton, Anita H, Lucas, Johna(2), DeRogatis, Leonard R, Jordan, Robert
- Database ID:
- RPEP-03244
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03244APA
Clayton, Anita H; Lucas, Johna; DeRogatis, Leonard R; Jordan, Robert. (2017). Phase I Randomized Placebo-controlled, Double-blind Study of the Safety and Tolerability of Bremelanotide Coadministered With Ethanol in Healthy Male and Female Participants.. Clinical therapeutics, 39(3), 514-526.e14. https://doi.org/10.1016/j.clinthera.2017.01.018
MLA
Clayton, Anita H, et al. "Phase I Randomized Placebo-controlled, Double-blind Study of the Safety and Tolerability of Bremelanotide Coadministered With Ethanol in Healthy Male and Female Participants.." Clinical therapeutics, 2017. https://doi.org/10.1016/j.clinthera.2017.01.018
RethinkPeptides
RethinkPeptides Research Database. "Phase I Randomized Placebo-controlled, Double-blind Study of..." RPEP-03244. Retrieved from https://rethinkpeptides.com/research/clayton-2017-phase-i-randomized-placebocontrolled
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.